http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-795473-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a157f5faa443ba5bb3367371f1e2a6c7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
filingDate 1978-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1981-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01bb044fdef77b2e69ce5a29a4eb9f2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_105f8eae675c0db046c8859921eee2b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd2e98ecc85e68bbcec9a77337679528
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9edfac74ed46efb103f84c7e92e1c529
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b47ffd1a49333df7fed7535aab4896d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_509a70345a284cfbda1216e00a332027
publicationDate 1981-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SU-795473-A3
titleOfInvention Method of preparing n-substituted n-2-(2-furylethyl)amines or their salts
abstract The novel N-2-(2-furylethyl)amines of the formula I, in which the symbols R<1>, R<2> and R<3> have the meaning given in Claim 1, have an inhibitory effect on the monoamide oxidases without having any unwanted amphetamine effect. They are prepared by reacting a compound of the formula II with a compound of the formula III, in which compounds one of the radicals A or B corresponds to the group <IMAGE> , in which R<2> has the above meaning, while the other represents halogen or a sulphonic acid ester group. <IMAGE>
priorityDate 1975-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6NSN2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ556K4
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449662972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7842
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424436622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ556K3
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392875
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54IT3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574862
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO18851
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8BW75
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP46882
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ64133
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24014
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5826
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21397
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1001
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27338
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21396
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP56560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574877

Total number of triples: 64.